04.26.12
Slovenia-based Vitiva has entered a new collaboration with Israel-based biotech company Naturamed based on an exclusive agreement to manufacture Naturamed Ltd.’s product line at Vitiva’s facilities and market it to the U.S. and Europe via Vitiva’s distribution channels. Ohad Cohen, CEO of Vitiva, said the goal of the partnership would be to develop innovative, yet traditional supplements for assisting in the relief of acute health problems. Naturamed is a biotech company that develops unique compounds extracted from specific strains of plant materials for improved natural treatment solutions. The company specifically focuses on products directed toward ameliorating benign prostatic hyperplasia (BPH).